We are all routinely exposed to carcinogenic DNAdamaging agents. It is assumed that we are protected from their tumorigenic effects in large part because many of the cells that incur potentially tumorigenic DNA damage undergo apoptosis (Hanahan and Weinberg, 2000; Green and Evan, 2002) . This implies that a decrease in the tissue expression of an endogenous antiapoptotic protein below wild-type levels could afford an individual protection from carcinogen-induced tumorigenesis. To our knowledge, this hypothesis has never been tested. Additionally, it is not clear how much the level of expression would have to be decreased to have a significant impact on susceptibility to tumorigenesis. In this context, it is notable that although mice haploinsufficient for the antiapoptotic protein Bcl-x L had been thought to be phenotypically normal (Boise et al., 1993) , we and others found that isolated cells from these mice demonstrate increased susceptibility to DNA damageinduced apoptosis in tissue culture experiments (Deverman et al., 2002; Maclean et al., 2003) . This suggested that the decreased levels of Bcl-x L in bcl-x þ /-mice might afford them resistance to tumorigenesis.
To test this, we assessed tumor formation in wild-type and bcl-x -/-mice 4 months after treatment with the lungspecific carcinogen urethane. Urethane induced a significantly greater (P ¼ 0.0002) number of tumors in the lungs of the wild-type mice compared with the number of tumors in the lungs of the bcl-x þ /-mice ( Figure 1a) . The difference in tumorigenesis was dramatic in that whereas greater than 40% of the wildtype mice were found to have more than seven tumors (ranging up to 24 tumors), none of the bcl-x þ /-mice developed more than seven tumors (Figure 1a ). Therefore, a decrease in Bcl-x L expression provides significant protection against urethane-induced lung tumorigenesis.
Notably, although the average tumor size was increased in the wild-type mice (Figure 1b) , the increase in size was proportionately less than the increase in tumor number. This suggests that a decrease in Bcl-x L affects tumor initiation to a greater extent than it affects tumor progression. The simplest explanation for this is that a larger portion of cells with low levels of Bcl-x L that have incurred potentially tumorigenic DNA damage die instead of developing into tumors, but Bcl-x L levels are relatively unimportant after tumorigenesis is initiated (although we note that Bcl-x L levels may be very important in determining the tumor response to treatment (Amundson et al., 2000) ).
The finding that wild-type levels of Bcl-x L promote tumorigenesis raises the question of why Bcl-x L is expressed in tissue at all. We thought it possible that the tissue level of Bcl-x L is a determinant of the threshold for certain types of injury. We chose to study the role of Bcl-x L in hepatic injury because hepatocellular Bcl-x L expression increases in response to several different hepatic insults: (1) ethanol ingestion increases murine hepatic Bcl-x L expression and Bcl-x L levels are increased in the livers of patients with alcoholic liver disease (Day, 2001; Natori et al., 2001; Ziol et al., 2001; Hong et al., 2002) ; (2) Bcl-x L expression is upregulated in isolated hepatocytes that are treated with either an anti-Fas antibody or TNF-a (Hatano and Brenner, 2001) ; (3) Bcl-x L expression is upregulated after partial hepatectomy (Tzung et al., 1997) . These findings suggested that changes in Bcl-x L levels within the physiologic range might have a role in determining the extent of hepatocellular injury that occurs in response to hepatic insult. Therefore, after confirming that Bcl-x L levels are indeed decreased in the livers of bcl-x þ /-mice (Figure 2a) , we compared the extent of hepatocellular injury in the response to ethanol ingestion in wild-type and bcl-x þ /-mice. The ethanol administration protocol we used mimicked a human 3-day alcoholic binge. The quantity of ethanol administered was chosen because we found that it caused behavioral changes that are consistent with the human form of moderate inebriation -the mice were ataxic when they were awake, but they remained arousable when they were asleep. bcl-x þ /-mice subjected to this protocol suffered increased hepatic damage compared with wild-type mice as evidenced by the finding that the ethanol induced a significantly greater increase in serum levels of alanine aminotransferase (ALT), a marker of liver injury, in the bcl-x þ /-mice at all time points at which the levels were assessed þ /-mice were crossed with A/J bcl-x þ / þ mice and 23 wild-type and 15 bclx þ /-mice from the F 1 generation were treated with the lung-specific carcinogen urethane at 8 weeks of age. The bcl-x þ /-mice were crossed into the A/J background because A/J mice are exquisitely susceptible to carcinogen-induced lung tumorigenesis (Shimkin and Stoner, 1975) . Mice were given a single injection of urethane 1 mg/g in 200 ml of PBS i.p. At 16 weeks after the injection, the lungs were fixed in Tellyesniczky's solution overnight and then stored in 70% ethanol. Tumors on the surface of the lungs were examined under a dissecting microscope to determine the number of tumors present and to measure the diameter of each tumor. Error bars in this and subsequent figures represent s.e.m. All studies in this article were performed in accordance with the protocols approved by the Washington University School of Medicine Animal Studies Commitee þ / þ and B6-129Sv bcl-x þ /-mice that were age and sex matched were used in the hepatic injury studies at 6-8 weeks of age. Only female mice were used for the ethanol studies because females of most mammalian species, including rodents, are more susceptible to alcohol-induced liver injury than males (Becker et al., 1996; Sato et al., 2001; Colantoni et al., 2003) . Ethanol 4 mg/g was administered by gavage as a 25% solution three times a day for 3 days and then the mice were killed. Alanine aminotransferase (ALT) was assessed at the indicated time points using an assay from Biotron Diagnostics (Hemet, CA, USA) as recommended by the manufacturer. This experiment was performed three times. Similar results were obtained each time. The livers from the mice were fixed in formalin overnight at 41C and then stored in 75% ethanol. TUNEL assays were performed using standard protocols. Studies were performed in accordance with protocols approved by the Washington University School of Medicine Animal Studies Committee (Figure 2b and c) . TUNEL staining was significantly increased (P ¼ 0.018) in the livers of the bcl-x þ /-mice, indicating that the damage was due at least in part to apoptosis (Figure 2d ) Therefore, Bcl-x L has an important role in protecting the liver from ethanolinduced injury. Additionally, these results strongly suggest that the increase in hepatocellular Bcl-x L expression that occurs in response to chronic ethanol abuse (Hong et al., 2002) affords further protection against injury.
TNF-a is thought to have an important role in the pathogenesis of a wide variety of liver disorders, including the viral hepatides (Gonzalez-Amaro et al., 1994) and fulminant hepatic failure (Muto et al., 1988) . Therefore, we next studied the importance of Bcl-x L in the hepatic response to TNF-a. TNF-a activates proapoptotic signals in the liver, but it also activates several potential antiapoptotic signals (Bradham et al., 1998; Diehl, 2000) . The antiapoptotic signaling is dominant over the proapoptotic signaling in the rodent liver as evidenced by the finding that TNF-a induces significantly increased hepatocellular apoptosis when administered with an inhibitor of transcription (Leist et al., 1994) . Strikingly, TNF-a treatment induced severe hepatocellular damage in bcl-x þ /-mice without the use of a transcriptional inhibitor. This was evidenced by markedly elevated serum ALT levels in TNF-a-treated bcl-x þ /-mice when compared with the serum ALT levels in the wild-type mice (Figure 3a and b) . The increased hepatocellular damage in the bcl-x þ /-mice was due at least in part to increased apoptosis as demonstrated by the significantly increased TUNEL (P ¼ 0.008) staining in the livers of the bcl-x þ /-mice ( Figure 3c ). These results indicate that Bcl-x L expression is a critical survival signal in the hepatocellular response to TNF-a, which implies that Bcl-x L has an important role in protecting the liver from injury in a wide variety of liver disorders.
Overexpression of Bcl-x L has previously been shown to promote tumorigenesis (Naik et al., 1996; Karnauskas et al., 2003) . We demonstrate here that even wild-type levels of Bcl-x L are tumorigenic when compared with the levels expressed in bcl-x þ /-mice. These findings strongly suggest that the level of Bcl-x L expression is a critical determinant of the susceptibility to at least some forms of tumorigenesis. This is consistent with the study by Amundson et al. (2000) in which it was found that among the several tumor cell proteins studied, the level of Bcl-x L expression had the highest correlation with resistance to antineoplastic therapy. It is likely that Bcl-x L is a critical determinant of both the susceptibility to tumorigenesis and the responsiveness to antineoplastic treatment in many tumor types. We note that in addition to reduced levels of Bcl-x L , it is likely that bcl-x þ /-mice express reduced levels of the proapoptotic Bcl-x protein Bcl-x s . Our results, however, suggest that the reduction of Bcl-x L is functionally dominant. Others have reached a similar conclusion (Taylor et al., 1999) .
Whereas we found that a decrease of Bcl-x L levels has a beneficial effect in respect to resistance to tumorigenesis, we also found that a decrease in Bcl-x L expression increases susceptibility to the effects of ethanol abuse and TNF-a treatment. These results add to a previous study in which it was demonstrated that a marked inhibition of hepatic Bcl-x L expression (>80% inhibition) with antisense sensitizes the liver to Fas-induced injury (Zhang et al., 2003) . Conversely, it has been found that transgenic mice that overexpress Bcl-x L in their livers are relatively resistant to hepatic injury (de la Coste et al., 1999) . Therefore, as is the case with susceptibility to tumorigenesis and responsiveness to antineoplastic treatment, the precise level of expression of Bcl-x L seems to be a critical determinant of the susceptibility to hepatic injury.
Importantly, TNF-a activates both death and survival signals in the liver (Leist et al., 1994; Bradham et al., 1998; Diehl, 2000; Yoon and Gores, 2002) . The balance of the signaling favors survival, as indicated by the finding that TNF-a-induced hepatocellular apoptosis is markedly increased in wild-type mice when the survival signals are blocked by inhibition of transcription. This is typically achieved by pretreatment of the mice with the liver-specific transcription inhibitor D-galactosamine (Leist et al., 1994; Bradham et al., 1998; Diehl, 2000) . The primary TNF-a-induced survival signal is thought to be the NF-kB-mediated upregulation of antiapoptotic proteins (Van Antwerp et al., 1998) . NF-kB has been shown to upregulate several antiapoptotic proteins, including c-IAP1, c-IAP2, TRAF1, TRAF2, Bfl/A1, and Bcl-x L (Chu et al., 1997; Wang et al., 1998 Wang et al., , 1999 Zong et al., 1999; Chen et al., 2000; Ravi et al., 2001) ; however, the relative importance of each of these proteins in NF-kB-mediated survival signaling in the liver has been unclear. Our finding that bcl-x þ /-mice are markedly more susceptible to TNF-a-induced hepatocellular apoptosis than wild-type mice is notable in that A single injection of TNF-a 2 mg in 500 ml of PBS was administered i.p. and the mice were killed 8 h after the injection it strongly suggests that Bcl-x L is a critical survival signal in the TNF-a response of wild-type mice.
Bcl-x L levels increase in response to certain physiologic and pathologic stimuli in several different types of tissue. Our data suggest that while the increases in Bcl-x L would serve to limit tissue injury, they would also increase the risk of developing a malignancy. There is significant evidence that this does indeed occur. For example, hepatic Bcl-x L levels are elevated in alcoholic liver disease (Hong et al., 2002) , which is likely to limit hepatocellular injury. However, patients with alcoholic liver disease are at a markedly increased risk for the development of hepatocellular carcinoma (Bergsland, 2001) . Our findings suggest that the increased risk of malignancy is due at least in part to the increased Bcl-x L levels. Another example is Barrett's esophagus, a metaplastic alteration of the esophageal mucosa that occurs in response to chronic gastroesophageal reflux (Riegman et al., 2001; McManus et al., 2004) . Bclx L expression is upregulated in the Barrett's mucosa when compared to its levels in the surrounding esophageal mucosa (Dvorakova et al., 2004) , and whereas the apoptotic index is low in the Barrett's mucosa, apoptosis is prominent in the surrounding mucosa (Wetscher et al., 1998) . Therefore, it is likely that the upregulation of Bcl-x L expression in the Barrett's mucosa is a protective mechanism. However, patients with Barrett's esophagus are at 30-60-fold increased risk of developing esophageal cancer (Cossentino and Wong, 2003) . Our data suggest that the increased Bcl-x L expression contributes to the increased cancer risk. It is likely that Bcl-x L expression increases in response to chronic injury in other tissues besides the liver and esophageal mucosa, and whereas the increased Bcl-x L expression protects against the injury, it, unfortunately, also increases susceptibility to malignant transformation.
